Advertisement
Review Article| Volume 50, ISSUE 2, P227-238, May 2023

Cystic Renal Masses

Old and New Paradigms
Published:February 20, 2023DOI:https://doi.org/10.1016/j.ucl.2023.01.003

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Urologic Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Silverman S.G.
        • Pedrosa I.
        • Ellis J.H.
        • et al.
        Bosniak classification of cystic renal masses, version 2019: an update proposal and needs assessment.
        Radiology. 2019; 292: 475-488
        • Krishna S.
        • Schieda N.
        • Pedrosa I.
        • et al.
        Update on MRI of cystic renal masses including Bosniak Version 2019.
        J Magn Reson Imaging. 2021; 54: 341-356
        • Sevcenco S.
        • Spick C.
        • Helbich T.H.
        • et al.
        Malignancy rates and diagnostic performance of the Bosniak classification for the diagnosis of cystic renal lesions in computed tomography: a systematic review and meta-analysis.
        Eur Radiol. 2016; 27: 2239-2247
        • Richard P.O.
        • Violette P.D.
        • Jewett M.A.S.
        • et al.
        CUA guideline on the management of cystic renal lesions.
        Can Urol Assoc J. 2017; 11: 66
        • Schoots I.G.
        • Zaccai K.
        • Hunink M.G.
        • et al.
        Bosniak Classification for Complex Renal Cysts reevaluated: a systematic review.
        J Urol. 2017; 198: 12-21
        • Smith A.D.
        • Remer E.M.
        • Cox K.L.
        • et al.
        Bosniak category IIF and III cystic renal lesions: outcomes and associations.
        Radiology. 2012; 262: 152-160
        • Bosniak M.A.
        The current radiological approach to renal cysts.
        Radiology. 1986; 158: 1-10
        • Hartman D.S.
        • Choyke P.L.
        • Hartman M.S.
        From the RSNA Refresher Courses: a practical approach to the cystic renal mass.
        Radiographics. 2004; 24: S101-S115
        • Heilbrun M.E.
        • Remer E.M.
        • Casalino D.D.
        • et al.
        ACR Appropriateness Criteria Indeterminate Renal Mass.
        J Am Coll Radiol. 2015; 12: 333-341
        • Chawla S.N.
        • Crispen P.L.
        • Hanlon A.L.
        • et al.
        The natural history of observed enhancing renal masses: meta-analysis and review of the world literature.
        J Urol. 2006; 175: 425-431
        • Kaza R.K.
        • Platt J.F.
        • Cohan R.H.
        • et al.
        Dual-energy CT with single- and dual-source scanners: current applications in evaluating the genitourinary tract.
        Radiographics. 2012; 32: 353-369
        • Maki D.D.
        • Birnbaum B.A.
        • Chakraborty D.P.
        • et al.
        Renal cyst pseudoenhancement: beam-hardening effects on CT numbers.
        Radiology. 1999; 213: 468-472
        • Tappouni R.
        • Kissane J.
        • Sarwani N.
        • et al.
        Pseudoenhancement of renal cysts: influence of lesion size, lesion location, slice thickness, and number of MDCT detectors.
        AJR Am J Roentgenol. 2012; 198: 133-137
        • Siddaiah M.
        • Krishna S.
        • McInnes M.D.F.
        • et al.
        Is ultrasound useful for further evaluation of homogeneously hyperattenuating renal lesions detected on CT?.
        AJR Am J Roentgenol. 2017; 209: 604-610
        • Park B.K.
        • Kim B.
        • Kim S.H.
        • et al.
        Assessment of cystic renal masses based on Bosniak classification: comparison of CT and contrast-enhanced US.
        Eur J Radiol. 2007; 61: 310-314
        • Herms E.
        • Weirich G.
        • Maurer T.
        • et al.
        Ultrasound-based “CEUS-Bosniak” classification for cystic renal lesions: an 8-year clinical experience.
        World J Urol. 2022; ([published online August 20)https://doi.org/10.1007/s00345-022-04094-0
        • Israel G.M.
        • Hindman N.
        • Bosniak M.A.
        Evaluation of cystic renal masses: comparison of CT and MR imaging by using the Bosniak classification system.
        Radiology. 2004; 231: 365-371
        • Ferreira A.M.
        • Reis R.B.
        • Kajiwara P.P.
        • et al.
        MRI evaluation of complex renal cysts using the Bosniak classification: a comparison to CT.
        Abdom Radiol. 2016; 41: 2011-2019
        • Ramamurthy N.K.
        • Moosavi B.
        • McInnes M.D.F.
        • et al.
        Multiparametric MRI of solid renal masses: pearls and pitfalls.
        Clin Radiol. 2015; 70: 304-316
        • Wang H.
        • Cheng L.
        • Zhang X.
        • et al.
        Renal cell carcinoma: diffusion-weighted MR imaging for subtype differentiation at 3.0 T.
        Radiology. 2010; 257: 135-143
        • Rosenkrantz A.B.
        • Wehrli N.E.
        • Mussi T.C.
        • et al.
        Complex cystic renal masses: comparison of cyst complexity and Bosniak classification between 1.5T and 3T MRI.
        Eur J Radiol. 2014; 83: 503-508
        • Volpe A.
        • Finelli A.
        • Gill I.S.
        • et al.
        Rationale for percutaneous biopsy and histologic characterisation of renal tumours.
        Eur Urol. 2012; 62: 491-504
        • Herrera-Caceres J.O.
        • Finelli A.
        • Jewett M.A.S.
        Renal tumor biopsy: indicators, technique, safety, accuracy results, and impact on treatment decision management.
        World J Urol. 2018; 37: 437-443
        • Richard P.O.
        • Jewett M.A.S.
        • Bhatt J.R.
        • et al.
        Renal tumor biopsy for small renal masses: a single-center 13-year experience.
        Eur Urol. 2015; 68: 1007-1013
        • Ljungberg B.
        • Albiges L.
        • Abu-Ghanem Y.
        • et al.
        European Association of Urology Guidelines on Renal Cell Carcinoma: the 2019 update.
        Eur Urol. 2019; 75: 799-810
        • Ma L.X.
        • Craig K.M.
        • Mosquera J.M.
        • et al.
        Contemporary results and clinical utility of renal mass biopsies in the setting of ablative therapy: a single center experience.
        Cancer Treat Res Commun. 2020; 25: 100209
        • Volpe A.
        • Mattar K.
        • Finelli A.
        • et al.
        Contemporary results of percutaneous biopsy of 100 small renal masses: a single center experience.
        J Urol. 2008; 180: 2333-2337
        • Marconi L.
        • Dabestani S.
        • Lam T.B.
        • et al.
        Systematic review and meta-analysis of diagnostic accuracy of percutaneous renal tumour biopsy.
        Eur Urol. 2016; 69: 660-673
        • Luomala L.
        • Rautiola J.
        • Järvinen P.
        • et al.
        Active surveillance versus initial surgery in the long-term management of Bosniak IIF–IV cystic renal masses.
        Sci Rep. 2022; 12
        • Sefik E.
        • Bozkurt I.H.
        • Adibelli Z.H.
        • et al.
        The histopathologic correlation of Bosniak 3 cyst subclassification.
        Urology. 2019; 129: 126-131
        • Westerman M.E.
        • Cheville J.C.
        • Lohse C.M.
        • et al.
        Long-term outcomes of patients with low grade cystic renal epithelial neoplasms.
        Urology. 2019; 133: 145-150
        • Williamson S.R.
        • Eble J.N.
        • Cheng L.
        • et al.
        Clear cell papillary renal cell carcinoma: differential diagnosis and extended immunohistochemical profile.
        Mod Pathol. 2013; 26: 697-708
        • Zhou H.
        • Zheng S.
        • Truong L.D.
        • et al.
        Clear cell papillary renal cell carcinoma is the fourth most common histologic type of renal cell carcinoma in 290 consecutive nephrectomies for renal cell carcinoma.
        Hum Pathol. 2014; 45: 59-64
        • Epstein J.
        • Netto G.J.
        Differential diagnoses in surgical pathology: genitourinary system.
        Lippincott Williams & Wilkins, Philadelphia, PA2021
        • Murad T.
        • Komaiko W.
        • Oyasu R.
        • et al.
        Multilocular cystic renal cell carcinoma.
        Am J Clin Pathol. 1991; 95: 633-637
        • Montironi R.
        • Mazzucchelli R.
        • Lopez-Beltran A.
        • et al.
        Cystic nephroma and mixed epithelial and stromal tumour of the kidney: opposite ends of the spectrum of the same entity?.
        Eur Urol. 2008; 54: 1237-1246
        • Sahni V.A.
        • Mortele K.J.
        • Glickman J.
        • et al.
        Mixed epithelial and stromal tumour of the kidney: imaging features.
        BJU Int. 2010; 105: 932-939
        • Adsay N.V.
        • Eble J.N.
        • Srigley J.R.
        • et al.
        Mixed epithelial and stromal tumor of the kidney.
        Am J Surg Pathol. 2000; 24: 958-970
        • Amin M.B.
        • MacLennan G.T.
        • Gupta R.
        • et al.
        Tubulocystic carcinoma of the kidney: clinicopathologic analysis of 31 cases of a distinctive rare subtype of renal cell carcinoma.
        Am J Surg Pathol. 2009; 33: 384-392
        • Honda Y.
        • Nakamura Y.
        • Goto K.
        • et al.
        Tubulocystic renal cell carcinoma: a review of literature focused on radiological findings for differential diagnosis.
        Abdom Radiol. 2018; 43: 1540-1545
        • Cornelis F.
        • Hélénon O.
        • Correas J.M.
        • et al.
        Tubulocystic renal cell carcinoma: a new radiological entity.
        Eur Radiol. 2015; 26: 1108-1115
        • Kuroda N.
        • Ohe C.
        • Mikami S.
        • et al.
        Review of acquired cystic disease-associated renal cell carcinoma with focus on pathobiological aspects.
        Histol Histopathol. 2011; 26: 1215-1218
        • Berkenblit R.
        • Ricci Z.
        • Kanmaniraja D.
        • et al.
        CT features of acquired cystic kidney disease-associated renal cell carcinoma.
        Clin Imaging. 2022; 83: 83-86
        • Chandrasekar T.
        • Ahmad A.E.
        • Fadaak K.
        • et al.
        Natural history of complex renal cysts: clinical evidence supporting active surveillance.
        J Urol. 2018; 199: 633-640
        • Kondo T.
        • Sassa N.
        • Yamada H.
        • et al.
        Comparable survival outcome between acquired cystic disease associated renal cell carcinoma and clear cell carcinoma in patients with end-stage renal disease: a multi-institutional central pathology study.
        Pathology. 2021; 53: 720-727
        • Halat S.K.
        • MacLennan G.T.
        Multilocular cystic renal cell carcinoma.
        J Urol. 2007; 177: 343
        • Srigley J.R.
        • Delahunt B.
        • Eble J.N.
        • et al.
        The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia.
        Am J Surg Pathol. 2013; 37: 1469-1489
        • Suzigan S.
        • López-Beltrán A.
        • Montironi R.
        • et al.
        Multilocular cystic renal cell carcinoma.
        Am J Clin Pathol. 2006; 125: 217-222
        • Rechsteiner M.P.
        • von Teichman A.
        • Nowicka A.
        • et al.
        VHL gene mutations and their effects on hypoxia inducible factor HIF: identification of potential driver and passenger mutations.
        Cancer Res. 2011; 71: 5500-5511
        • Nassir A.
        • Jollimore J.
        • Gupta R.
        • et al.
        Multilocular cystic renal cell carcinoma: a series of 12 cases and review of the literature.
        Urology. 2002; 60: 421-427
        • Wahal S.P.
        • Mardi K.
        Multilocular cystic renal cell carcinoma: a rare entity with review of literature.
        J Lab Physicians. 2014; 6: 050-052
        • Bhatt J.R.
        • Jewett M.A.S.
        • Richard P.O.
        • et al.
        Multilocular cystic renal cell carcinoma: pathological T staging makes no difference to favorable outcomes and should be reclassified.
        J Urol. 2016; 196: 1350-1355
        • Webster W.S.
        • Thompson R.H.
        • Cheville J.C.
        • et al.
        Surgical resection provides excellent outcomes for patients with cystic clear cell renal cell carcinoma.
        Urology. 2007; 70: 900-904
        • Boissier R.
        • Ouzaid I.
        • Nouhud F.X.
        • et al.
        Long-term oncological outcomes of cystic renal cell carcinoma according to the Bosniak classification.
        Int Urol Nephrol. 2019; 51: 951-958
        • Kashan M.
        • Ghanaat M.
        • Hötker A.M.
        • et al.
        Cystic renal cell carcinoma: a report on outcomes of surgery and active surveillance in patients retrospectively identified on pretreatment imaging.
        J Urol. 2018; 200: 275-282
        • Tretiakova M.
        • Mehta V.
        • Kocherginsky M.
        • et al.
        Predominantly cystic clear cell renal cell carcinoma and multilocular cystic renal neoplasm of low malignant potential form a low-grade spectrum.
        Virchows Arch. 2018; 473: 85-93
        • Diolombi M.L.
        • Cheng L.
        • Argani P.
        • et al.
        Do clear cell papillary renal cell carcinomas have malignant potential?.
        Am J Surg Pathol. 2015; 39: 1621-1634
        • Couvidat C.
        • Eiss D.
        • Verkarre V.
        • et al.
        Renal papillary carcinoma: CT and MRI features.
        Diagn Interv Imaging. 2014; 95: 1055-1063
        • Egbert N.D.
        • Caoili E.M.
        • Cohan R.H.
        • et al.
        Differentiation of papillary renal cell carcinoma subtypes on CT and MRI.
        AJR Am J Roentgenol. 2013; 201: 347-355
        • Procházková K.
        • Mírka H.
        • Trávníček I.
        • et al.
        Cystic appearance on imaging methods (Bosniak III-IV) in histologically confirmed papillary renal cell carcinoma is mainly characteristic of papillary renal cell carcinoma type 1 and might predict a relatively indolent behavior of papillary renal cell carcinoma.
        Urol Int. 2018; 101: 409-416
        • Lane B.R.
        • Campbell S.C.
        • Remer E.M.
        • et al.
        Adult cystic nephroma and mixed epithelial and stromal tumor of the kidney: clinical, radiographic, and pathologic characteristics.
        Urology. 2008; 71: 1142-1148
        • Chu L.C.
        • Hruban R.H.
        • Horton K.M.
        • et al.
        Mixed epithelial and stromal tumor of the kidney: radiologic-pathologic correlation.
        Radiographics. 2010; 30: 1541-1551
        • Caliò A.
        • Eble J.N.
        • Grignon D.J.
        • et al.
        Cystic nephroma in adults.
        Am J Surg Pathol. 2016; 40: 1591-1600
        • Tse J.R.
        • Shen J.
        • Shen L.
        • et al.
        Bosniak Classification of Cystic Renal Masses Version 2019: comparison of categorization using CT and MRI.
        AJR Am J Roentgenol. 2021; 216: 412-420
        • Rasmussen R.G.
        • Xi Y.
        • Sibley R.C.
        • et al.
        Association of clear cell likelihood score on MRI and growth kinetics of small solid renal masses on active surveillance.
        AJR Am J Roentgenol. 2022; 218: 101-110
        • Finelli A.
        • Cheung D.C.
        • Al-Matar A.
        • et al.
        Small renal mass surveillance: histology-specific growth rates in a biopsy-characterized cohort.
        Eur Urol. 2020; 78: 460-467
        • Mason R.J.
        • Abdolell M.
        • Trottier G.
        • et al.
        Growth kinetics of renal masses: analysis of a prospective cohort of patients undergoing active surveillance.
        Eur Urol. 2011; 59: 863-867
        • Crispen P.L.
        • Viterbo R.
        • Boorjian S.A.
        • et al.
        Natural history, growth kinetics, and outcomes of untreated clinically localized renal tumors under active surveillance.
        Cancer. 2009; 115: 2844-2852
        • Bhindi B.
        • Thompson R.H.
        • Lohse C.M.
        • et al.
        The probability of aggressive versus indolent histology based on renal tumor size: implications for surveillance and treatment.
        Eur Urol. 2018; 74: 489-497
        • Goenka A.H.
        • Remer E.M.
        • Smith A.D.
        • et al.
        Development of a clinical prediction model for assessment of malignancy risk in Bosniak III renal lesions.
        Urology. 2013; 82: 630-635
        • Mousessian P.N.
        • Yamauchi F.I.
        • Mussi T.C.
        • et al.
        Malignancy rate, histologic grade, and progression of Bosniak category III and IV complex renal cystic lesions.
        AJR Am J Roentgenol. 2017; 209: 1285-1290
        • Smith A.D.
        • Allen B.C.
        • Sanyal R.
        • et al.
        Outcomes and complications related to the management of Bosniak cystic renal lesions.
        AJR Am J Roentgenol. 2015; 204: W550-W556
        • Smith A.D.
        • Carson J.D.
        • Sirous R.
        • et al.
        Active surveillance versus nephron-sparing surgery for a Bosniak IIF or III renal cyst: a cost-effectiveness analysis.
        AJR Am J Roentgenol. 2019; 212: 830-838
        • Miskin N.
        • Qin L.
        • Matalon S.A.
        • et al.
        Stratification of cystic renal masses into benign and potentially malignant: applying machine learning to the Bosniak classification.
        Abdom Radiol. 2020; 46: 311-318
        • Choyke P.L.
        The Bosniak classification gets even better.
        Radiology. 2020; 297: 606-607
        • Winters B.R.
        • Gore J.L.
        • Holt S.K.
        • et al.
        Cystic renal cell carcinoma carries an excellent prognosis regardless of tumor size.
        Urol Oncol. 2015; 33 (e9-e13): 505
        • Donin N.M.
        • Mohan S.
        • Pham H.
        • et al.
        Clinicopathologic outcomes of cystic renal cell carcinoma.
        Clin Genitourin Cancer. 2015; 13: 67-70
        • Couture F.
        • Finelli A.
        • Tétu A.
        • et al.
        Management of complex renal cysts in Canada: results of a survey study.
        BMC Urol. 2020; 20https://doi.org/10.1186/s12894-020-00614-5
        • Campbell S.C.
        • Uzzo R.G.
        • Karam J.A.
        • et al.
        Renal mass and localized renal cancer: evaluation, management, and follow-up: AUA Guideline: Part II.
        J Urol. 2021; 206: 209-218
      1. 89Zr-TLX250 for PET/CT Imaging of ccRCC – ZIRCON Study. Clinical Trials.gov identifier: NCT03849118.
        (Available at:) (Updated November 10, 2022. Accessed November 28, 2022)
        • Ricketts C.J.
        • De Cubas A.A.
        • Fan H.
        • et al.
        The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma.
        Cell Rep. 2018; 23 (e5): 313-326
        • Turajlic S.
        • Xu H.
        • Litchfield K.
        • et al.
        Tracking cancer evolution reveals constrained routes to metastases: TRACERx Renal.
        Cell. 2018; 173 (e12): 581-594
        • Turajlic S.
        • Xu H.
        • Litchfield K.
        • et al.
        Deterministic evolutionary trajectories influence primary tumor growth: TRACERx Renal.
        Cell. 2018; 173 (e11): 595-610
        • Nuzzo P.V.
        • Berchuck J.E.
        • Korthauer K.
        • et al.
        Detection of renal cell carcinoma using plasma and urine cell-free DNA methylomes.
        Nat Med. 2020; 26: 1041-1043